Loading summary
Indiana University Narrator
Indiana University is shaping the future of healthcare, advancing discoveries that become treatments for Alzheimer's, obesity, cancer and rare diseases and training the providers trusted to deliver them from the lab to the clinic. IU powers medical breakthroughs and the talent behind them. See how IU solves what's next IU Edu Impact.
Cathie Wood
Bloomberg Audio Studios Podcasts Radio.
Interviewer 1
News the Ark Invest CEO Cathie Wood, one of Tesla's biggest bulls, the EV maker, the top holding in her flagship innovation etf, has this to say. I do not understand why investors are voting against Elon's pay package when they and their clients would benefit enormously if he and his incredible team meet such high goals. Kathy joins us now for more. Kathy, thanks for making some time for us this morning. Good morning to you all. Do you think, Kathy, the incentives are well aligned?
Cathie Wood
Yes, we do. I do not believe any company anywhere near this size has ever delivered a compound annual rate of growth for EBITDA, which is a bottom line number of 41% over 10 years. No company has done that. So yes, indeed, the incentives are aligned. If he and his team are able to deliver on that number, the stock is going to outperform enormously.
Interviewer 2
Kathy, if by chance this proposal is rejected, would you consider shedding some of your Tesla position?
Cathie Wood
So I'm happy that the prediction markets are at 90 to 95% in terms of this is going through, so we don't have to think about that. Clearly. If Elon left, we think about it in two ways. One, we think robotaxis. He has them the starting gate as of June and now they're rolling out and that AI project is well underway. If he had left five years ago, three years ago, it probably wouldn't be anywhere near where it is. What we now think though is in order to capitalize on humanoid robots, which, that's a much more difficult project that, yes, Elon's brilliance and the team he has attracted around him are going to be necessary to pull that off. Our price target, $2600 in 2030 is 90% of that valuation is Robo taxi. We have very little for humanoid robots. If humanoid robots evolve as as quickly as Elon thinks. Now remember, that's Elon time, but he already has a running start because robotaxis are robots. They're electric, they're powered by AI. Those are the three innovation platforms that will power humanoid robots as well. So he's ahead of the game on that one as well. But I do believe he's the right leader to bring that part of the story to Life as well.
Interviewer 1
Kathy, I've got to ask you this, though, to follow up on Lisa's question. If you wouldn't sell if he wasn't CEO, then why should we pay him that much to be the CEO?
Cathie Wood
What I'm saying is we would feel comfortable with the robot, Robotaxi part of the model, but we would not be able to build with confidence the humanoid robot part of the model. So over time, of course, as the, as the story would depend more and more on that leg of the story, we would be taking our position down.
Interviewer 2
You talked earlier, Kathy, the past couple of days about this reality check that's going on in the tech sector. And I understand that Tesla is sort of in its own place that you do hold them for the long term. How do you understand the reality check that's currently going on within a lot of the biggest tech stocks and this sense of skepticism about whether they can keep growing at that rate versus the long term? Bullish bet.
Cathie Wood
You know, I'm really happy that there is so much skepticism out there. Anyone who went through the late 90s will remember there was no skepticism. And we had valuations based on the number of eyeballs balls on a website maybe 10 years from then. We're not seeing that right now. We are seeing, wait a minute, they're spending a lot of money on these data centers. This is a little bit of a different story than I was investing in. Certainly in terms of when I say I, the average investor was investing in with the Mag 6, those were just cash cows and, and had huge cash position. Everything's changing here. It's making the, the typical investor a little more, I'll say, skeptical that this is not just the cash register ringing anymore. This is, wait, a big bet on the future. So I'm happy there's skepticism. I think it's a good thing.
Interviewer 2
Are you buying right now? Are you seeing the skepticism as a chance to build some of your portfolio?
Cathie Wood
Oh, sure. You know, and probably the most undervalued part of our portfolios is in life is health care. Because we think that is going to present the most profound application of AI out there. And yet it is highly underappreciated because, you know, health care analysts aren't comfortable with tech and tech analysts aren't comfortable with health health care. And you know, we've got a very siloed ecosystem in terms of the way research is done at ahrq. We're very focused on the technologies first and how they're going to scale across sectors. So our analysts are organized by technology and think there's a huge inefficiency there.
Interviewer 1
Kathy, thanks for being so generous with your time this morning. We appreciate it. Cathy Wood that the Ark Invest CEO on Elon Musk of Tesla and a.
Hiscox Insurance Narrator
Whole lot more Hiscock Small Business Insurance knows there is no business like your business. Across America, over 600,000 small businesses, from accountants and architects to photographers and yoga instructors, look to Hiscox Insurance for protection. Find flexible coverage that adapts to the needs of your small business with a fast, easy online'@hiscox.com that's his C O X com. There's no business like small business. Hiscox Small Business Insurance.
Date: November 6, 2025
Host: Bloomberg
Guest: Cathie Wood (CEO & CIO of Ark Invest)
Episode Focus: Cathie Wood discusses Tesla, Elon Musk’s pay package, AI in healthcare, current tech sector skepticism, and Ark Invest’s portfolio strategy.
In this episode, the Bloomberg team interviews Cathie Wood, CEO and CIO of Ark Invest, known for her high-conviction bets on innovation and disruptive technology. The conversation spotlights her continued bullish stance on Tesla, thoughts on Elon Musk’s controversial pay package, the importance of leadership for ambitious projects like robotaxis and humanoid robots, and her broader perspective on market skepticism and underappreciated investment sectors.
Alignment of Incentives:
"I do not believe any company anywhere near this size has ever delivered a compound annual rate of growth for EBITDA... of 41% over 10 years. No company has done that... If he and his team are able to deliver on that number, the stock is going to outperform enormously."
— Cathie Wood, 00:56
Impact of Musk Leaving Tesla:
“He already has a running start because robotaxis are robots. They're electric, they're powered by AI. Those are the three innovation platforms that will power humanoid robots as well. So he's ahead of the game on that one as well.”
— Cathie Wood, 02:39
Why Paying Musk Matters:
“Over time, of course, as the story would depend more and more on that leg of the story, we would be taking our position down.”
— Cathie Wood, 03:34
Wood distinguishes today’s tech landscape from the late 1990s dot-com bubble, noting that skepticism is prevalent and healthy.
“Anyone who went through the late 90s will remember there was no skepticism. And we had valuations based on the number of eyeballs balls on a website maybe 10 years from then. We're not seeing that right now.”
— Cathie Wood, 04:13
Skepticism as an Opportunity:
AI’s Underappreciated Role in Healthcare:
“Probably the most undervalued part of our portfolios is… healthcare. Because we think that is going to present the most profound application of AI out there. And yet it is highly underappreciated because... healthcare analysts aren't comfortable with tech and tech analysts aren't comfortable with health care.”
— Cathie Wood, 05:22
Ark’s Unique Research Approach:
“We're very focused on the technologies first and how they're going to scale across sectors. So our analysts are organized by technology and think there's a huge inefficiency there.”
— Cathie Wood, 05:46
"Our price target, $2,600 in 2030 is 90% of that valuation is Robo taxi."
— Cathie Wood, 02:22
"If [humanoid robots] evolve as quickly as Elon thinks. Now remember, that's Elon time..."
— Cathie Wood, 02:30
"We're not seeing... valuations based on the number of eyeballs balls on a website maybe 10 years from then. We're not seeing that right now."
— Cathie Wood, 04:15
"Health care analysts aren't comfortable with tech and tech analysts aren't comfortable with health care... there's a huge inefficiency there."
— Cathie Wood, 05:39
Cathie Wood offered robust defenses for Elon Musk’s leadership and compensation as crucial to Tesla’s continued innovation, particularly in autonomous vehicles and robotics. She differentiated today’s market skepticism from past bubbles, and emphasized the undervalued opportunity in healthcare AI, highlighting Ark’s technology-first approach. The discussion showcased Wood’s conviction in disruptive innovation, her strategic long-term perspective, and her belief in cross-disciplinary thinking as an edge in investing.